Previous 10 | Next 10 |
2024-02-08 13:55:22 ET Summary I am an income-oriented investor focused on high-yield closed-end funds and ETFs to compound returns in retirement. Income investing requires picking investments that provide a steady distribution, rather than trying to time the market. I discuss...
ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ®...
2024-01-26 10:25:55 ET Summary Prior to December 31, 2023, my REaders mentioned 34 equities in their comments on my articles. Some bad-news investments (ROgues) mixed with (mostly) FAvorites. Thus, these are ReFa/Ro. Ten analyst-target-estimated TOP-NET-GAIN Re/Fa/Ro: KVUE, PFE, T...
2024-01-18 10:43:45 ET Summary abrdn, a UK-based fund manager, has been aggressively acquiring and merging closed-end funds aka CEFs from other managers to expand its offerings. CEFs have advantages over traditional dividend-paying stocks and offer a wide range of asset types and ...
2024-01-08 13:16:54 ET Summary The number of retirees in the U.S. is growing rapidly, with as many as 10,000 new retirees a day. Retirees with income from employment, pensions, or investments are generally better off than those relying solely on Social Security. By investing i...
2024-01-07 00:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- CLS-AX is a Highly Potent Tyrosine Kinase Inhibitor Delivered Suprachoroidally Using Clearside’s SCS Microinjector ® - - Randomization Completed in ODYSSEY Phase 2b Clinical Trial - - Topline Data Expected in Q3 2024 - ALPHARETTA, Ga., Dec. 14...
2023-12-11 05:00:42 ET A safe double-digit yield makes it a lot easier to retire. Today we’ll discuss a portfolio that pays 14.1% (that’s no typo). The math on 14.1% looks awesome. This yield generates $14,100 on a $100K every year. Or $141,000 on a million dollar port...
2023-12-06 04:45:13 ET Summary Cornerstone Strategic Value Fund is a closed-end fund with a 19% yield, but its NAV has declined significantly since its inception. The fund's strategy cannibalizes capital and relies on the return of capital to maintain its distribution plan. CL...
2023-12-05 13:25:43 ET Summary CLM's distribution strategy relies heavily on divestitures of its asset base, making it unsustainable. The recent dividend cut did not significantly improve CLM's prospects, as the forward annualized dividend yield is still overly aggressive. CLM...
News, Short Squeeze, Breakout and More Instantly...
Cornerstone Strategic Value Fund Inc. Company Name:
CLM Stock Symbol:
NYSE Market:
- Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET - - Retina Specialists to Provide Insights and Real-World Experience with Suprachoroidal Drug Delivery - - Target Profile for CLS-AX in Wet AMD Landscape and Potential Opportunities for Clearside Pipeline Expansion - ...
- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - Robust Safety Profile and Encouraging Efficacy Data Reported Utilizing SCS Microinjector ® - ALPHARETTA, Ga., June 12, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc....
2024-06-10 15:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...